Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 9027597, 8 pages
https://doi.org/10.1155/2017/9027597
Research Article

Description and Validation of TAVIApp: A Novel Mobile Application for Support of Physicians in the Management of Aortic Stenosis—Management of Aortic Stenosis with TAVIApp

1Division of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy
2URT-CNR, Department of Medicine, Consiglio Nazionale delle Ricerche, Catanzaro, Italy
3Institute of Forensic Medicine, Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy
4The Ethics Committee, Regione Calabria, Sezione Area Centro, Catanzaro, Italy

Correspondence should be addressed to Ciro Indolfi; ti.zcinu@iflodni

Received 15 May 2017; Accepted 11 October 2017; Published 15 November 2017

Academic Editor: Gianluca Di Bella

Copyright © 2017 Ciro Indolfi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Aortic stenosis (AS) is the most common heart valve disease in developed countries. The advent of transcatheter aortic valve implantation (TAVI) significantly improved patients’ outcome but made clinical management more complex. The aim of the present study was to describe TAVIApp, a mobile app we developed to guide the management of AS, and test its efficacy. Methods and Results. Clinical cases comprising 42 patients with AS were blindly evaluated by (A) an interventional cardiologist, assisted by the Heart Team (EXPERT), (B) young residents in cardiology, and (C) a young resident supported by TAVIApp. There was poor concordance between Group A and Group B with low performance by young residents (; ). However, concordance increased to an optimal value when young residents were supported by TAVIApp (; ) for the diagnosis of severe AS and eligibility assessment. Furthermore, regarding the selection of the most appropriate prosthesis size, concordance to Group A was poor without TAVIApp support (Group B) (; ), but excellent with TAVIApp (; ). Conclusions. This study is the first describing and validating a new mobile application to support the management of AS. TAVIApp supports cardiologists in the evaluation of stenosis severity, eligibility for TAVI or AVR, and selection of the most appropriate prosthesis size in individual patients.